CRSP vs MRNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
CRSP
MRNA
Investment Advisor Scores
MRNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CRSP | MRNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.3645 | 23.0415 | MRNA |
| PEG Ratio | -0.2142 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1041.4% | 2.1% | CRSP |
| Earnings Growth | 0.0% | -85.1% | CRSP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.2/100 | 41.2/100 | CRSP |
| Profit Margin | 0.0% | -141.4% | CRSP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CRSP
NeutralMixed signals - no dominant trend phase, RSI 40
MRNA
NeutralMixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | CRSP | MRNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -14.1 | -42.4 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 10.4% | 0.0% |
| Gross Margin | -34.5% | -0.7% |
| Operating Margin | -11.3% | -5.6% |
| EPS | -4.74 | -8.10 |
| Dividend Yield | — | — |